Oracle
ORCL
Vale SA
VALE
Toll Brothers
TOL
4
D.R. Horton
DHI
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
PRME Prime Medicine
- 1.660
- -0.030-1.78%
Close Apr 28 16:00 ET
- 1.660
- 0.0000.00%
Post 16:48 ET
217.73MMarket Cap-1.01P/E (TTM)
1.790High1.615Low1.16MVolume1.690Open1.690Pre Close1.93MTurnover1.81%Turnover RatioLossP/E (Static)131.16MShares8.27052wk High1.42P/B106.47MFloat Cap1.11552wk Low--Dividend TTM64.14MShs Float21.730Historical High--Div YieldTTM10.36%Amplitude1.115Historical Low1.670Avg Price1Lot Size
About Prime Medicine Company
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
Company Profile
SymbolPRME
Company NamePrime Medicine
Listing DateOct 20, 2022
Issue Price17.00
Founded2019
CEODr. Keith Gottesdiener, M.D.
MarketNASDAQ
Employees214
Fiscal Year Ends12-31
Address60 First Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141-2300
Phone1-617-465-0013
Websitehttp://www.primemedicine.com
Company Executives
- Name
- Position
- Salary
- Dr. Keith Gottesdiener, M.D.
- President, Chief Executive Officer and Director
- 2.25M
- Carman Alenson
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Richard H. Brudnick
- Chief Business Officer
- --
- Dr. Jeremy Duffield
- Chief Scientific Officer
- 1.88M
- Dr. Ann L. Lee, PhD
- Chief Technical Officer
- --
- Dr. Allan Reine, M.D.
- Chief Financial Officer
- 4.62M
- Dr. Meredith Goldwasser
- Senior Vice President, Strategy and Corporate Operations
- --
- Jeffrey D. Marrazzo
- Director
- 1.82M
- Kaye Foster
- Independent Director
- 294.53K
- Robert Taylor Nelsen
- Independent Director
- 287.59K
- Michael A. Kelly
- Independent Director
- 298.78K
- Dr. Wendy K. Chung, M.D.,PhD
- Independent Director
- 294.72K
- Dr. Thomas Cahill, PhD
- Independent Director
- 294.72K
- Dr. David P. Schenkein, M.D.
- Independent Director
- 297.59K
- Andrew Anzalone, M.D.,PhD
- Head of Prime Editing Platform
- --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call